Miyamoto S - Search Results

1

Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.

Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: miyamoto s. Gynecol Oncol. 2005 Jun;97(3):772-9. doi: 10.1016/j.ygyno.2005.02.025. Epub 2005 Apr 15. Gynecol Oncol. 2005. PMID: 15943986

2

Invasive potency related to RCAS1 expression in uterine cervical cancer.

Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: miyamoto s. Gynecol Oncol. 2005 Oct;99(1):189-98. doi: 10.1016/j.ygyno.2005.06.061. Gynecol Oncol. 2005. PMID: 16112176

3

Clinical significance of RCAS1 as a biomarker of uterine cancer.

Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: miyamoto s. Gynecol Oncol. 2006 Dec;103(3):924-31. doi: 10.1016/j.ygyno.2006.05.047. Epub 2006 Jul 13. Gynecol Oncol. 2006. PMID: 16842844

4

Clinical significance of RCAS1 as a biomarker of ovarian cancer.

Sonoda K, Miyamoto S, Yotsumoto F, Yagi H, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: miyamoto s. Oncol Rep. 2007 Mar;17(3):623-8. Oncol Rep. 2007. PMID: 17273743

5

Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.

Sonoda K, Miyamoto S, Yamazaki A, Kobayashi H, Nakashima M, Mekada E, Wake N. Sonoda K, et al. Among authors: miyamoto s. Cancer. 2007 Nov 1;110(9):1979-90. doi: 10.1002/cncr.23015. Cancer. 2007. PMID: 17849467 Free article.

6

The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis.

Sonoda K, Miyamoto S, Nakashima M, Wake N. Sonoda K, et al. Among authors: miyamoto s. Front Biosci. 2008 Jan 1;13:1106-16. doi: 10.2741/2748. Front Biosci. 2008. PMID: 17981616 Review.

7

Association between RCAS1 expression and clinical outcome in uterine endometrial cancer.

Sonoda K, Miyamoto S, Hirakawa T, Kaku T, Nakashima M, Watanabe T, Akazawa K, Fujita T, Nakano H. Sonoda K, et al. Among authors: miyamoto s. Br J Cancer. 2003 Aug 4;89(3):546-51. doi: 10.1038/sj.bjc.6601126. Br J Cancer. 2003. PMID: 12888828 Free PMC article.

8

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.

Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E, Nakano H. Fujita T, et al. Among authors: miyamoto s. Cancer Lett. 2003 Mar 31;192(2):161-9. doi: 10.1016/s0304-3835(02)00713-9. Cancer Lett. 2003. PMID: 12668280

9

Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.

Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, Kai M, Kanoh H, Nakano H, Mekada E. Miyamoto S, et al. Cancer Res. 2004 Aug 15;64(16):5720-7. doi: 10.1158/0008-5472.CAN-04-0811. Cancer Res. 2004. PMID: 15313912

10

Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.

Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H. Tanaka Y, et al. Among authors: miyamoto s. Clin Cancer Res. 2005 Jul 1;11(13):4783-92. doi: 10.1158/1078-0432.CCR-04-1426. Clin Cancer Res. 2005. PMID: 16000575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,391 results

Search Page

Filters